Hyperhomocysteinemia and recurrent carotid stenosis

Area of Science:

• Vascular Surgery
• Cardiovascular Disease
• Clinical Chemistry

Background:

• Hyperhomocysteinemia is a suspected risk factor for atherosclerotic disease.
• The role of elevated serum homocysteine in restenosis post-carotid endarterectomy (CEA) requires further investigation.

Purpose of the Study:

• To investigate the association between elevated serum homocysteine levels and the development of restenosis after CEA.
• To determine if higher homocysteine concentrations are linked to increased restenosis risk.

Main Methods:

• Retrospective analysis of 96 patients undergoing CEA.
• Comparison of fasting plasma homocysteine levels between patients with and without restenosis (defined as ≥50% stenosis via duplex scan).
• Subgroup analysis of early (3-18 months) and late (≥19 months) restenosis.

Main Results:

• Patients who developed restenosis had significantly lower mean homocysteine levels (9.11 µmol/L) compared to those without restenosis (11.01 µmol/L; p=0.03).
• No significant difference in homocysteine levels was observed between early and late restenosis groups (p=0.50).
• Groups were controlled for age, sex, diabetes, nicotine abuse, weight, hypertension, and hyperlipidemia.

Conclusions:

• Elevated plasma homocysteine concentrations do not appear to be a significant risk factor for restenosis following CEA.
• The study's findings suggest an inverse or non-existent relationship between homocysteine and restenosis in this context.